Medicare Enrolled
Dr. Jeannine Laramie, MD
Family Medicine · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Laramie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laramie?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Laramie
Dr. Jeannine Laramie is a family medicine specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Laramie performed 1,739 Medicare services across 1,262 unique beneficiaries.
Between the years covered by Open Payments, Dr. Laramie received a total of $21,037 from 59 pharmaceutical and/or device companies across 1032 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Laramie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in CA
$21,037 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,739
Medicare services
Top 12% in CA for family medicine
1,262
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~92 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
427 | $82 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
357 | $58 | $85 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
202 | $83 | $100 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
195 | $134 | $135 |
| Annual depression screening | 190 | $20 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
175 | $111 | $165 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
46 | $72 | $75 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
46 | $32 | $35 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
24 | $33 | $75 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
24 | $12 | $30 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $35 | $55 |
| Prolonged preventive service, first 30 minutes This code covers the first 30 minutes of direct patient contact time spent on preventive services that exceeds the typical duration of the primary procedure. It is billed in addition to the code for the primary preventive service. |
17 | $65 | $120 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
15 | $3 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,037
Total received (2018-2024)
Avg $3,005/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,032
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,549 (92.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,311 (6.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$178 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,396
2023
$2,353
2022
$2,134
2021
$4,137
2020
$2,392
2019
$3,001
2018
$4,624
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$559
ABBVIE INC.
$333
Amgen Inc.
$194
Axsome Therapeutics, Inc.
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$168
Lilly USA, LLC
$162
Mylan Specialty L.P.
$117
Novo Nordisk Inc
$113
PFIZER INC.
$89
Lundbeck LLC
$69
Novartis Pharmaceuticals Corporation
$67
Otsuka America Pharmaceutical, Inc.
$54
Phathom Pharmaceuticals, Inc.
$37
Exact Sciences Corporation
$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
IRONWOOD PHARMACEUTICALS, INC
$30
Azurity Pharmaceuticals, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$25
E.R. Squibb & Sons, L.L.C.
$25
Merck Sharp & Dohme LLC
$19
GlaxoSmithKline, LLC.
$18
Esperion Therapeutics, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$14
Top 3 companies account for 45.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,578
AstraZeneca Pharmaceuticals LP
$2,190
Novo Nordisk Inc
$1,608
Biohaven Pharmaceuticals, Inc.
$1,311
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,217
ABBVIE INC.
$938
Amarin Pharma Inc.
$772
GlaxoSmithKline, LLC.
$731
Lilly USA, LLC
$701
Novartis Pharmaceuticals Corporation
$683
PFIZER INC.
$639
Takeda Pharmaceuticals U.S.A., Inc.
$621
Janssen Pharmaceuticals, Inc
$610
Mylan Specialty L.P.
$601
AbbVie Inc.
$552
Kowa Pharmaceuticals America, Inc.
$420
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$384
Otsuka America Pharmaceutical, Inc.
$378
SANOFI-AVENTIS U.S. LLC
$322
Allergan Inc.
$295
Axsome Therapeutics, Inc.
$277
E.R. Squibb & Sons, L.L.C.
$262
Astellas Pharma US Inc
$251
Ironwood Pharmaceuticals, Inc
$223
Merck Sharp & Dohme LLC
$200
Merck Sharp & Dohme Corporation
$198
Allergan, Inc.
$194
Sunovion Pharmaceuticals Inc.
$166
IDORSIA PHARMACEUTICALS US INC
$131
Esperion Therapeutics, Inc.
$124
Bayer Healthcare Pharmaceuticals Inc.
$117
Biohaven Pharmaceutical Holding Company Ltd.
$116
BioDelivery Sciences International, Inc.
$105
Lundbeck LLC
$95
Abbott Laboratories
$94
IRONWOOD PHARMACEUTICALS, INC
$75
Akcea Therapeutics, Inc.
$73
Exact Sciences Corporation
$68
Bayer HealthCare Pharmaceuticals Inc.
$61
Synergy Pharmaceuticals Inc
$60
Teva Pharmaceuticals USA, Inc.
$57
Daiichi Sankyo Inc.
$57
Avanir Pharmaceuticals, Inc.
$51
Amneal Pharmaceuticals LLC
$50
Noden Pharma USA Inc
$45
Nevro Corp.
$42
Phathom Pharmaceuticals, Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$37
AbbVie, Inc.
$32
Azurity Pharmaceuticals, Inc.
$28
Grifols USA, LLC
$22
Medtronic, Inc.
$21
Coloplast Corp
$21
Boston Scientific Corporation
$21
GENZYME CORPORATION
$18
SANOFI PASTEUR INC.
$15
AMAG Pharmaceuticals, Inc.
$15
Arbor Pharmaceuticals, Inc.
$14
Horizon Therapeutics plc
$14
Top 3 companies account for 30.3% of all-time payments
Associated products mentioned in payments ›
ADACEL · AIRSUPRA · AJOVY · ANORO · AVYCAZ · Aimovig · Altis · Amitiza · Auvelity · BASAGLAR · BELBUCA · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BYSTOLIC · CHANTIX · COMIRNATY · CREON · CYCLOSET · Cologuard Collection Kit · DALVANCE · DIFICID · DUPIXENT · DUZALLO · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FreeStyle Libre · HORIZANT · HUMALOG · INJECTAFER · INTELLIS · INTRAROSA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LIVALO · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MOTEGRITY · MOUNJARO · MYRBETRIQ · Motegrity · NEXLETOL · NUEDEXTA · NURTEC ODT · OFEV · Omnia · Otezla · Ozempic · PRALUENT · PREMARIN · PREVNAR 20 · Perforomist · Proclaim Family of SCS IPGs · Prolastin-C Liquid · Prolia · QULIPTA · QUVIVIQ · RELISTOR ORAL · REXULTI · RYBELSUS · RYTARY · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TEGSEDI · TEKTURNA · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · Utibron · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Victoza · Vyvanse · WATCHMAN · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
359
Per 100K population
35.5
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Laramie is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Laramie experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Laramie performed 427 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laramie receive payments from pharmaceutical companies?
Yes. Dr. Laramie received a total of $21,037 from 59 companies across 1,032 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laramie's costs compare to other family medicine physicians in Fresno?
Dr. Laramie's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laramie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Fresno
Browse family medicine physicians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology